1.1M Flu Doses Given in Québec; INSPQ Says Positivity May Have Plateaued
Quebec residents have received 1.1 million influenza vaccine doses one month into the current immunization campaign, showing a strong public response despite the introduction of fees for non-priority groups.
According to Noovo Info, this volume represents an increase of approximately 131,000 doses compared to the same period last year, aligning vaccination rates with the 2024-2025 winter season figures.
Key Clinical Takeaways:
- Over 1.1 million flu vaccine doses have been administered across Quebec within the first month of the campaign.
- Influenza positivity rates stabilized at approximately 12% in early November, though health authorities warn the seasonal peak has not yet occurred.
- Vaccination remains free for high-risk populations, including seniors, those with chronic conditions, pregnant women, and healthcare workers.
The current influenza season arrived earlier than historical norms, with positivity rates climbing significantly by October. Data from the Institut national de santé publique du Québec (INSPQ) indicates that influenza test positivity reached 12.2% during the week of November 1, followed by 12.1% the week of November 8, according to Noovo Info.
While these figures suggest a temporary plateau, the INSPQ noted in correspondence with La Presse Canadienne that this stabilization may be transient, as similar mid-season lulls have been documented in previous years.
Public health officials emphasize that the vaccine requires roughly 14 days to elicit a strong antibody response. This biological window is critical as the province approaches the holiday season, a period typically associated with heightened transmission of respiratory viruses. Santé Québec maintains that the majority of available appointment slots are currently occupied, indicating strong engagement from the target demographics.
Efforts to protect vulnerable populations are concentrated in private seniors’ residences (RPAs) and long-term care facilities (CHSLDs). As of the latest reporting, over 150,000 doses—covering both influenza and COVID-19—have been administered in RPAs, an increase of 28,000 doses compared to the same 30-day window last year.
Specifically, nearly 80,000 flu-only doses were provided to RPA residents, up from 63,000 during the prior campaign. In CHSLDs, the uptake remains consistent with a three-year trend, totaling approximately 33,000 doses.
| Vaccine Campaign Metric | Current Season (30 Days) | Year-Over-Year Change |
|---|---|---|
| Influenza Doses Administered | 1.1 Million | +131,000 |
| COVID-19 Doses Administered | 810,000 | +120,000 |
| RPA Combined Doses | 150,000 | +28,000 |
Despite the high volume of vaccinations, healthcare infrastructure remains under strain. Santé Québec reports that it is too early to provide a definitive assessment of the campaign’s impact on emergency room attendance. Officials anticipate that hospital traffic will likely increase as the season progresses, noting that the peak of emergency department occupancy has not yet been reached.
To mitigate the risk of severe morbidity and potential hospitalizations, the province continues to urge high-risk individuals—specifically those 65 and older and those with chronic medical conditions—to prioritize vaccination.
For individuals who have not yet received their doses or who require clinical guidance on managing respiratory symptoms, it is advisable to contact a primary care physician or consult with a board-certified general practitioner to determine the appropriate course of action before visiting an emergency department.
The success of the remaining vaccination rollout, particularly in congregate living settings, remains a central factor in preventing systemic overflow during the coming weeks. Whether these administrative efforts will sufficiently curb the burden on emergency services remains an open question as public health agencies continue to monitor viral circulation and clinical outcomes.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.